Has Melvin Scheinman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $259,605 in general payments to Melvin Scheinman, MD across 326 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Melvin Scheinman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Melvin Scheinman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Melvin Scheinman, MD

Internal Medicine · San Francisco, CANPI 1225087109

Payments from drug & device makers

$259,605in general payments, 2019–2025

Across 326 payments — averaging $796.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biotronik Inc.$70K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$57K
Medical Device Business Services, Inc.$52K
Abbott$50K
Boston Scientific$15K
Biosense Webster, Inc.$7K
plus $8K from 5 others

What the payments were for

Consulting fees$69,81727%
Speaking & faculty fees$128,22549%
Grants$1,7351%
Travel & lodging$49,31219%
Food & beverage$10,5044%
Education$130%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biotronik Inc.	81	$70,486
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	37	$56,880
Medical Device Business Services, Inc.	27	$52,220
Abbott	132	$50,253
Boston Scientific	26	$15,118
Biosense Webster, Inc.	10	$7,031
Medtronic(2 entities)	8	$5,340
Altathera Pharmaceuticals LLC	2	$1,188
Pfizer	1	$1,050
Amgen	1	$27
Johnson & Johnson	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$259,605 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Medicare billing

Part B allowed, 2024

$1,453

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in San Francisco

Rahul AggarwalSan Francisco$24M
Thomas MartinSan Francisco$13.7M
Peter HuntSan Francisco$9.8M
Diane HavlirSan Francisco$8.4M
Sandy WongSan Francisco$6.6M
Nina ShahSan Francisco$5.4M
Katy TsaiSan Francisco$3.8M
Riley BoveSan Francisco$3.6M
Jacob LalezariSan Francisco$3.3M
Flavio VincentiSan Francisco$2.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →